Who Owns Rigel Pharmaceuticals Inc (RIGL)? 13F Institutional Holders (Q2 2026)

RIGL ranks #3569 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

RIGL is a top-conviction position for CM Management, LLC — at 6.2% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in RIGL belongs to BlackRock, Inc., but the position matters far more to CM Management, LLC, who has 6.2% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

American Century Companies Inc has added to its RIGL position for two straight quarters, increasing it by $18.1M to reach $29.0M today.

Goldman Sachs Group Inc has trimmed its RIGL position for two straight quarters, cutting it by $19.9M while still holding $8.9M.

RIGL is down 0.6% today, but institutions show net buying of $66.3M this quarter — a divergence between today's price move and the underlying institutional flow.

RIGL posted net income of $321.9M over the trailing twelve months, and currently trades at a P/E of 2.7.

• Profitable — net income of $321.9M over the trailing twelve months
• Revenue grew 3.3% year over year
• Net income improved year over year, from $97.8M to $321.9M
• Generated $75.7M in positive operating cash flow
• Current ratio of 2.42x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.31x equity — within a conventional range